Network analysis of human in-stent restenosis

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Genomics

Background:

• Drug-eluting stents show success but challenges remain for in-stent restenosis (ISR).
• Human coronary atheroma in de novo and restenotic disease requires further investigation for novel therapeutic targets.

Purpose of the Study:

• To identify novel therapeutic targets for in-stent restenosis (ISR) by analyzing human coronary atheroma.
• To compare gene expression profiles in de novo atherosclerosis and ISR.
• To evaluate potential therapeutic agents based on gene network analysis.

Main Methods:

• Recruited 89 patients undergoing coronary atherectomy for de novo atherosclerosis or ISR.
• Performed histological analysis and gene expression profiling using oligonucleotide microarrays.
• Utilized network analysis combining literature mining with gene expression signatures.

Main Results:

• ISR samples showed greater cellularity and less inflammation/lipid content compared to de novo lesions.
• Gene ontology revealed cell proliferation in ISR and inflammation in de novo disease.
• Network analysis identified procollagen type 1 alpha2 and ADAM17 as potential ISR targets.
• Sirolimus demonstrated broader suppressive action against ISR than paclitaxel in network analysis.

Conclusions:

• Histological and gene network analysis of human ISR provides potential targets for directed therapy.
• The findings support the clinical efficacy of existing agents like sirolimus and paclitaxel.
• This approach can identify and validate therapeutic targets for restenotic disease.